Phase III microbicide trial methodology: opinions of experienced expanded safety trial participants in South Africa

In preparation for effectiveness trials of candidate vaginal microbicides, scientists are debating trial design and implementation challenges, including choice of control arm(s), product-sharing across arms, and visit schedules.This study involved a survey of South African women participating in an expanded safety trial of the candidate microbicide

read more

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

U-Omp19 is a bacterial protease inhibitor from Brucella abortus that inhibits gastrointestinal and lysosomal proteases, enhancing the half-life and immunogenicity of co-delivered antigens.U-Omp19 is a novel adjuvant that is in preclinical development with various vaccine Serum candidates.However, the molecular mechanisms by which it exerts these fu

read more



Chiral Supramolecular Hydrogel Loaded with Dimethyloxalyglycine to Accelerate Chronic Diabetic Wound Healing by Promoting Cell Proliferation and Angiogenesis

Chronic refractory wounds are one of the most serious complications of diabetes, and the effects of common treatments are limited.Chiral hydrogel combined with dimethyloxalyglycine (DMOG) as a dressing is a promising strategy for the treatment of chronic wounds.In this research, we have developed a DMOG-loaded supramolecular chiral amino-acid-deriv

read more